Free Trial

Bowen Hanes & Co. Inc. Purchases Shares of 140,000 National Health Investors, Inc. $NHI

National Health Investors logo with Finance background

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Bowen Hanes & Co. Inc. bought a new position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 140,000 shares of the real estate investment trust's stock, valued at approximately $10,340,000. Bowen Hanes & Co. Inc. owned 0.30% of National Health Investors as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the stock. Wells Fargo & Company MN grew its stake in shares of National Health Investors by 8.3% during the 4th quarter. Wells Fargo & Company MN now owns 76,072 shares of the real estate investment trust's stock worth $5,272,000 after acquiring an additional 5,853 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of National Health Investors during the 4th quarter worth approximately $2,219,000. Sterling Capital Management LLC grew its stake in shares of National Health Investors by 61.1% during the 4th quarter. Sterling Capital Management LLC now owns 3,099 shares of the real estate investment trust's stock worth $215,000 after acquiring an additional 1,175 shares in the last quarter. Barclays PLC grew its stake in shares of National Health Investors by 7.6% during the 4th quarter. Barclays PLC now owns 77,122 shares of the real estate investment trust's stock worth $5,344,000 after acquiring an additional 5,419 shares in the last quarter. Finally, Mariner LLC grew its stake in shares of National Health Investors by 26.3% during the 4th quarter. Mariner LLC now owns 4,295 shares of the real estate investment trust's stock worth $298,000 after acquiring an additional 894 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on NHI. Truist Financial raised their price target on shares of National Health Investors from $77.00 to $81.00 and gave the stock a "buy" rating in a research note on Friday, August 15th. KeyCorp raised shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price for the company in a research note on Thursday, July 10th. Finally, Wedbush raised shares of National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, National Health Investors presently has an average rating of "Buy" and a consensus price target of $85.40.

Check Out Our Latest Research Report on NHI

National Health Investors Stock Up 0.6%

Shares of NYSE:NHI traded up $0.4520 during midday trading on Friday, hitting $77.7420. The stock had a trading volume of 244,628 shares, compared to its average volume of 230,533. The business's 50-day simple moving average is $72.05 and its 200-day simple moving average is $72.57. National Health Investors, Inc. has a 12 month low of $65.13 and a 12 month high of $86.13. The company has a market cap of $3.69 billion, a P/E ratio of 24.84, a PEG ratio of 3.34 and a beta of 0.73. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.06. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The business had revenue of $70.27 million during the quarter, compared to the consensus estimate of $86.46 million. During the same quarter last year, the firm posted $1.18 EPS. The company's quarterly revenue was up 6.7% on a year-over-year basis. On average, sell-side analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.68 annualized dividend and a yield of 4.7%. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. National Health Investors's payout ratio is 115.02%.

About National Health Investors

(Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Read More

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.